Knockdown of S100A2 inhibits the aggressiveness of endometrial cancer by activating STING pathway

Background Endometrial cancer is a kind of gynaecological cancer. S100A2 is a newfound biomarker to diagnose endometrial cancer. This study was to investigate the role of S100A2 on regulating migration and invasion of endometrial cancer.Methods The mRNA and protein levels of S100A2 were obtained by...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengcheng Li (Author), Dandan Zhu (Author), Xun Cao (Author), Ying Li (Author), Xiaoyuan Hao (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available